Literature DB >> 15481755

Acute hepatic sequestration in sickle cell disease.

William E Norris1.   

Abstract

Sickle cell anemia is a disease that affects one out of every 600 African Americans. It is often debilitating and can cause many physical restrictions to individuals with the disease. The disease has many complications which can be vexing for patients and their physicians. The hepatic complications attributed to vascular occlusion encompass a variety of clinical syndromes of which the relationship among clinical presentation, biochemical findings, and histologic features remains unclear. The conditions range from the self-limiting hepatic right upper quadrant syndrome (hepatic crisis) to the potentially lethal intrahepatic cholestasis and acute hepatic sequestration syndromes. Few cases have been documented, and there have not been many sizable studies on acute hepatic sequestration in sickle cell disease. This case is useful for clinicians who are not familiar with the intrahepatic vaso-occlusive syndromes in sickle cell disease. It provides insight into the presentation, diagnosis, and management of these syndromes.

Entities:  

Mesh:

Year:  2004        PMID: 15481755      PMCID: PMC2568451     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  16 in total

1.  Successful treatment of hepatitis C in sickle-cell disease.

Authors:  M W Swaim; S Agarwal; W F Rosse
Journal:  Ann Intern Med       Date:  2000-11-07       Impact factor: 25.391

Review 2.  Sickle cell hepatopathy.

Authors:  S Banerjee; C Owen; S Chopra
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

3.  Serum alkaline phosphatase isoenzymes in sickle cell anemia.

Authors:  J I Brody; W N Ryan; M A Haidar
Journal:  JAMA       Date:  1975-05-19       Impact factor: 56.272

4.  Sickle cell hepatopathy.

Authors:  T W Sheehy
Journal:  South Med J       Date:  1977-05       Impact factor: 0.954

5.  Resolution of chronic hepatic sequestration in a patient with homozygous sickle cell disease receiving hydroxyurea.

Authors:  Michael R Jeng; Martha D Rieman; Paula E Naidu; Sue C Kaste; Jesse J Jenkins; Graham Serjeant; Winfred C Wang
Journal:  J Pediatr Hematol Oncol       Date:  2003-03       Impact factor: 1.289

6.  Progression of iron overload in sickle cell disease.

Authors:  N F Olivieri
Journal:  Semin Hematol       Date:  2001-01       Impact factor: 3.851

7.  Frequency of sickling disorders in U.S. blacks.

Authors:  A G Motulsky
Journal:  N Engl J Med       Date:  1973-01-04       Impact factor: 91.245

Review 8.  Gastrointestinal pathology in sickle cell disease.

Authors:  J S Krauss; L J Freant; J R Lee
Journal:  Ann Clin Lab Sci       Date:  1998 Jan-Feb       Impact factor: 1.256

9.  Exchange transfusion for sickle cell intrahepatic cholestasis.

Authors:  T W Sheehy; D E Law; B H Wade
Journal:  Arch Intern Med       Date:  1980-10

10.  Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy.

Authors:  Nada Zakaria; Alex Knisely; Bernard Portmann; Giorgina Mieli-Vergani; Julia Wendon; Roopen Arya; John Devlin
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

View more
  8 in total

Review 1.  Management of liver complications in sickle cell disease.

Authors:  Abid R Suddle
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Liver stiffness increases acutely during sickle cell vaso-occlusive crisis.

Authors:  Christopher Koh; Tiffany Turner; Xiongce Zhao; Caterina P Minniti; Jordan J Feld; Jennifer Simpson; Mary Demino; Anna K Conrey; Mary J Jackson; Catherine Seamon; David E Kleiner; Gregory J Kato; Theo Heller
Journal:  Am J Hematol       Date:  2013-08-01       Impact factor: 10.047

Review 3.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

Review 4.  Sickle cell disease: a neglected chronic disease of increasing global health importance.

Authors:  Subarna Chakravorty; Thomas N Williams
Journal:  Arch Dis Child       Date:  2014-09-19       Impact factor: 3.791

5.  Unrecognized hemoglobin SC sickle cell disease complicated by sepsis and cholestasis.

Authors:  Thomas McFarland; David Spillane; Elizaveta Chernetsova; Kaberi Dasgupta
Journal:  CMAJ       Date:  2022-05-02       Impact factor: 16.859

6. 

Authors:  Thomas McFarland; David Spillane; Elizaveta Chernetsova; Kaberi Dasgupta
Journal:  CMAJ       Date:  2022-08-22       Impact factor: 16.859

7.  Successful Outcome of Chronic Intrahepatic Cholestasis in an Adult Patient with Sickle Cell/ β (+) Thalassemia.

Authors:  Efthymia Vlachaki; Panagiotis Andreadis; Nikolaos Neokleous; Aleka Agapidou; Evaggelia Vetsiou; Panagiotis Katsinelos; Panagiota Boura
Journal:  Case Rep Hematol       Date:  2014-02-09

8.  Asymptomatic Hepatic Sequestration with Extreme Hyperbilirubinemia in an Adult Homozygous Sickle Cell Patient.

Authors:  Syed Musa Raza; Mehdi Faraji; Omar Khan; Rimsha Shaukat
Journal:  Cureus       Date:  2020-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.